128 results
Page 3 of 7
8-K
EX-99.1
rmshmkyl swc4e
4 Nov 21
Adaptimmune Reports Third Quarter Financial Results and Business Update
7:40am
8-K
EX-99.1
31f2iq
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am
8-K
EX-99.1
qvjfqqviex65qmf9qq6
9 Aug 21
Adaptimmune Reports Second Quarter Financial Results and Business Update
4:08pm
8-K
EX-99.1
ezwr17zh
6 May 21
Adaptimmune Reports First Quarter Financial Results and Business Update
7:38am
8-K
EX-99.1
e9mlp8v5eph 87gt
25 Feb 21
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
7:37am
8-K
EX-10.1
m9ue757
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.1
qtoll xgnt
5 Nov 20
Adaptimmune Reports Q3 Financial Results and Business Update
7:40am
S-3ASR
646nsywu
10 Aug 20
Automatic shelf registration
5:01pm
8-K
EX-99.1
wvsy yyusht
6 Aug 20
Adaptimmune Reports Q2 Financial Results and Business Update
7:37am
424B5
pfnn8bcg963bu72qb1
2 Jun 20
Prospectus supplement for primary offering
5:05pm
424B5
zfgr9n5s3ea5
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-99.1
1v4w1g35i
14 May 20
Adaptimmune Reports Q1 Financial Results
7:37am